We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Ask ADVFN Intelligence (AI)
Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program PR Newswire WALTHAM, Mass., Dec. 10, 2024 -- SIGNAL-AA demonstrated encouraging...
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Nov. 7, 2024 -- Bempikibart Phase 2 topline results in atopic dermatitis (AD) and...
Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference PR Newswire WALTHAM, Mass., Nov. 5, 2024 WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.21 | 6.40243902439 | 3.28 | 3.58 | 3.26 | 144798 | 3.44628755 | CS |
| 4 | 0.17 | 5.12048192771 | 3.32 | 4.1499 | 2.99 | 296110 | 3.44161362 | CS |
| 12 | -43.51 | -92.5744680851 | 47 | 51.2569 | 2.99 | 391904 | 8.418146 | CS |
| 26 | -32.72 | -90.3617785142 | 36.21 | 53.79 | 2.99 | 230899 | 17.13490783 | CS |
| 52 | -12.75 | -78.5098522167 | 16.24 | 53.79 | 2.99 | 161898 | 18.31477531 | CS |
| 156 | -12.75 | -78.5098522167 | 16.24 | 53.79 | 2.99 | 161898 | 18.31477531 | CS |
| 260 | -12.75 | -78.5098522167 | 16.24 | 53.79 | 2.99 | 161898 | 18.31477531 | CS |
herbied47
1 month ago
Law of Averages
1 month ago
Contrarian Way
3 months ago
Monksdream
4 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
